Literature DB >> 8057137

Genetics of primary brain tumors: a review.

M Bondy1, J Wiencke, M Wrensch, A P Kyritsis.   

Abstract

In this review we provide evidence for the existence of genes associated with primary malignant brain tumors. We summarize the current knowledge from studies of familial cancer aggregation, hereditary syndromes, and molecular and cytogenetic studies. The epidemiologic evidence is suggestive but inconclusive for an association between brain tumors and cancers in other family members, including cancers of the breast, lung and colon. Central nervous system (CNS) tumors have been associated with several hereditary syndromes including the Li-Fraumeni cancer family syndrome, neurofibromatosis (types 1 and 2), tuberous sclerosis, nevoid basal cell carcinoma syndrome, familial polyposis, and von Hippel-Lindau disease. Significant studies leading to the recognition of molecular and cytogenetic abnormalities in malignant gliomas are described in detail. The genetic studies conducted thus far suggest a role for inherited susceptibility in some CNS tumors.

Entities:  

Mesh:

Year:  1994        PMID: 8057137     DOI: 10.1007/bf01324606

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  120 in total

1.  An exploratory case-control study of brain tumors in adults.

Authors:  J D Burch; K J Craib; B C Choi; A B Miller; H A Risch; G R Howe
Journal:  J Natl Cancer Inst       Date:  1987-04       Impact factor: 13.506

2.  Neurofibromatosis and childhood tumors.

Authors:  J Blatt; R Jaffe; M Deutsch; J C Adkins
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

3.  Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.

Authors:  P A Humphrey; L M Gangarosa; A J Wong; G E Archer; M Lund-Johansen; R Bjerkvig; O D Laerum; H S Friedman; D D Bigner
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

6.  Expression of the p53 protein in a spectrum of astrocytic tumours.

Authors:  D W Ellison; K C Gatter; P V Steart; D P Lane; R O Weller
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 8.  p53: the ultimate tumor suppressor gene?

Authors:  M Oren
Journal:  FASEB J       Date:  1992-10       Impact factor: 5.191

9.  Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue.

Authors:  U Diedrich; S Soja; J Behnke; B Zoll
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

10.  Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis.

Authors:  M R Hurtt; J Moossy; M Donovan-Peluso; J Locker
Journal:  J Neuropathol Exp Neurol       Date:  1992-01       Impact factor: 3.685

View more
  16 in total

Review 1.  Brain tumors and polyomaviruses.

Authors:  Sidney Croul; Jessica Otte; Kamel Khalili
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

Authors:  Adelheid Wöhrer; Thomas Waldhör; Harald Heinzl; Monika Hackl; Johann Feichtinger; Ulrike Gruber-Mösenbacher; Andreas Kiefer; Hans Maier; Reinhard Motz; Angelika Reiner-Concin; Bernd Richling; Carmen Idriceanu; Michael Scarpatetti; Roland Sedivy; Hans-Christian Bankl; Wolfgang Stiglbauer; Matthias Preusser; Karl Rössler; Johannes Andreas Hainfellner
Journal:  J Neurooncol       Date:  2009-06-28       Impact factor: 4.130

3.  DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma.

Authors:  Guanqian Yuan; Dandan Gao; Shaofeng Ding; Jun Tan
Journal:  Tumour Biol       Date:  2014-01-23

4.  Genetic Contribution of Polymorphisms in Glutathione S-Transferases to Brain Tumor Risk.

Authors:  Peiliang Geng; Jianjun Li; Ning Wang; Juanjuan Ou; Ganfeng Xie; Rina Sa; Chen Liu; Lisha Xiang; Hongtao Li; Houjie Liang
Journal:  Mol Neurobiol       Date:  2015-03-04       Impact factor: 5.590

Review 5.  Mitogens as motogens.

Authors:  M R Chicoine; D L Silbergeld
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 6.  Inherited predisposition to glioma.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Jasti S Rao; Chrissa Sioka
Journal:  Neuro Oncol       Date:  2009-11-23       Impact factor: 12.300

Review 7.  Initial management of childhood brain tumors: neurosurgical considerations.

Authors:  Farideh Nejat; Mostafa El Khashab; James T Rutka
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Brain cancer mortality in the United States, 1986 to 1995: a geographic analysis.

Authors:  Zixing Fang; Martin Kulldorff; David I Gregorio
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

Review 9.  Familial syndromes associated with intracranial tumours: a review.

Authors:  Adrianna M Ranger; Yatri K Patel; Navjot Chaudhary; Ram V Anantha
Journal:  Childs Nerv Syst       Date:  2013-11-06       Impact factor: 1.475

10.  Aggregation of cancer in first-degree relatives of patients with glioma.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Randa El-Zein; Gladstone E Airewele; Beatrice Malmer; Kenneth D Aldape; Jeffrey S Weinberg; W K Alfred Yung; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.